Roche Holding AG (RHHBY)
OTCMKTS
· Delayed Price · Currency is USD
40.11
+0.59 (1.49%)
Apr 28, 2025, 10:23 AM EDT
Roche Holding AG Employees
Roche Holding AG had 103,249 employees as of December 31, 2024. The number of employees decreased by 356 or -0.34% compared to the previous year.
Employees
103,249
Change (1Y)
-356
Growth (1Y)
-0.34%
Revenue / Employee
$666,883
Profits / Employee
$88,465
Market Cap
253.38B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 103,249 | -356 | -0.34% |
Dec 31, 2023 | 103,605 | -8 | -0.01% |
Dec 31, 2022 | 103,613 | 2,693 | 2.67% |
Dec 31, 2021 | 100,920 | -545 | -0.54% |
Dec 31, 2020 | 101,465 | 3,730 | 3.82% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 3,116 |
Glass House Brands | 374 |
Northwest Biotherapeutics | 25 |
Elite Pharmaceuticals | 64 |
CytoDyn | 9 |
American Oncology Network | 1,914 |
Silence Therapeutics | 116 |
Longduoduo Company | 49 |
Roche Holding AG News
- 17 hours ago - 'Roche could've earned over 100 times what it cost for rare disease drug' - The Times of India
- 20 hours ago - Notable healthcare headlines for the week: Merck, Roche and Bausch Health in focus - Seeking Alpha
- 1 day ago - Zealand Pharma says obesity drug deal with Roche will help it stay independent - Financial Times
- 3 days ago - Roche: Key Products Stall, Obesity Pipeline Takes Shape - Seeking Alpha
- 3 days ago - New England Journal of Medicine publishes phase III data showing single-dose Xofluza significantly reduces influenza virus transmission - GlobeNewsWire
- 3 days ago - New England Journal of Medicine Publishes Phase III Data Showing Single-dose Xofluza Significantly Reduces Influenza Virus Transmission - Business Wire
- 3 days ago - Roche Holding AG (RHHBY) Q1 2025 Sales/ Trading Statement Call Transcript - Seeking Alpha
- 4 days ago - Pharma Giant Roche Tops First-Quarter Views; Sanofi's Sales Come In Mixed - Investor's Business Daily